Pharmacological blockade and genetic absence of the dopamine D2 receptor specifically modulate voluntary locomotor activity in mice

Behavioural Brain Research

Volumn 242, Issue 1, 2013, Pages 117-124

  Klinker, Florian ^a   Hasan, Kenan ^a   Paulus, Walter ^a   Nitsche, Michael A ^a   Liebetanz, David ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

D2 receptor; Dopamine; Locomotor activity; Mice; Running wheel

Indexed keywords

DOPAMINE 2 RECEPTOR; RACLOPRIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REBOUND; RUNNING; SIGNAL TRANSDUCTION; TREADMILL; VOLUNTARY MOVEMENT;

ANALYSIS OF VARIANCE; ANIMALS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; RACLOPRIDE; RECEPTORS, DOPAMINE D2; TIME FACTORS;

EID: 84872451817     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.12.038     Document Type: Article

References (29)

1. Millan M.J., Seguin L., Gobert A., Cussac D., Brocco M. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats. Psychopharmacology (Berlin) 2004, 174:341-357.
2. Bronikowski A.M., Rhodes J.S., Garland T., Prolla T.A., Awad T.A., Gammie S.C. The evolution of gene expression in mouse hippocampus in response to selective breeding for increased locomotor activity. Evolution 2004, 58:2079-2086.
3. Lightfoot J.T., Turner M.J., Pomp D., Kleeberger S.R., Leamy L.J. Quantitative trait loci for physical activity traits in mice. Physiological Genomics 2008, 32:401-408.
4. Simonen R.L., Rankinen T., Perusse L., Rice T., Rao D.C., Chagnon Y., et al. Genome-wide linkage scan for physical activity levels in the Quebec family study. Medicine and Science in Sports and Exercise 2003, 35:1355-1359.
5. Knab A.M., Lightfoot J.T. Does the difference between physically active and couch potato lie in the dopamine system. International Journal of Biological Science 2010, 6:133-150.
6. Arnsten A.F. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. Journal of Clinical Psychiatry 2006, 67(Suppl. 8):7-12.
7. Gelegen C., van den Heuvel J., Collier D.A., Campbell I.C., Oppelaar H., Hessel E., et al. Dopaminergic and brain-derived neurotrophic factor signalling in inbred mice exposed to a restricted feeding schedule. Genes, Brain, and Behavior 2008, 7:552-559.
8. Pirke K.M., Broocks A., Wilckens T., Marquard R., Schweiger U. Starvation-induced hyperactivity in the rat: the role of endocrine and neurotransmitter changes. Neuroscience and Biobehavioral Reviews 1993, 17:287-294.
9. Volkow N.D., Wang G.J., Newcorn J., Telang F., Solanto M.V., Fowler J.S., et al. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Archives of General Psychiatry 2007, 64:932-940.
10. Baik J.H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 1995, 377:424-428.
11. Chausmer A.L., Elmer G.I., Rubinstein M., Low M.J., Grandy D.K., Katz J.L. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice. Psychopharmacology (Berlin) 2002, 163:54-61.
12. Rowlett J.K., Mattingly B.A., Bardo M.T. Repeated quinpirole treatment: locomotor activity, dopamine synthesis, and effects of selective dopamine antagonists. Synapse 1995, 20:209-216.
13. Sevak R.J., Owens W.A., Koek W., Galli A., Daws L.C., France C.P. Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats. Journal of Neurochemistry 2007, 101:151-159.
14. Tanabe L.M., Suto N., Creekmore E., Steinmiller C.L., Vezina P. Blockade of D2 dopamine receptors in the VTA induces a long-lasting enhancement of the locomotor activating effects of amphetamine. Behavioural Pharmacology 2004, 15:387-395.
15. Kelly M.A., Rubinstein M., Phillips T.J., Lessov C.N., Burkhart-Kasch S., Zhang G., et al. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1998, 18:3470-3479.
16. Eikelboom R. Human parallel to voluntary wheel running: exercise. Animal Behaviour 1999, 57. F11-F2.
17. Wise R.A., Carlezon W.A. Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride. Synapse 1994, 17:155-159.
18. Simonen R.L., Rankinen T., Perusse L., Leon A.S., Skinner J.S., Wilmore J.H., et al. A dopamine D2 receptor gene polymorphism and physical activity in two family studies. Physiology & Behavior 2003, 78:751-757.
19. Clifford J.J., Kinsella A., Tighe O., Rubinstein M., Grandy D.K., Low M.J., et al. Comparative, topographically-based evaluation of behavioural phenotype and specification of D(1)-like:D(2) interactions in a line of incipient congenic mice with D(2) dopamine receptor 'knockout'. Neuropsychopharmacology 2001, 25:527-536.
20. Drago F., Contarino A., Busa L. The expression of neuropeptide-induced excessive grooming behavior in dopamine D1 and D2 receptor-deficient mice. European Journal of Pharmacology 1999, 365:125-131.
21. Khaldy H., Leon J., Escames G., Bikjdaouene L., Garcia J.J., Acuna-Castroviejo D. Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinology 2002, 75:201-208.
22. Weiner D.M., Levey A.I., Sunahara R.K., Niznik H.B., O'Dowd B.F., Seeman P., et al. D1 and D2 dopamine receptor mRNA in rat brain. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:1859-1863.
23. Rusak B., Zucker I. Neural regulation of circadian rhythms. Physiological Reviews 1979, 59:449-526.
24. Sanberg P.R. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature 1980, 284:472-473.
25. Ahlenius S., Ericson E.L., Hogberg K., Wijkstrom A. Behavioural and biochemical effects of subchronic treatment with raclopride in the rat: tolerance and brain monoamine receptor sensitivity. Pharmacology & Toxicology 1991, 68:302-309.
26. Suresh P.S., Punde R.R., Gupta M., Dixit A., Giri S., Rajagopal S., et al. A highly sensitive LC-MS/MS method for the determination of S-raclopride in rat plasma: application to a pharmacokinetic study in rats. Biomedical Chromatography (BMC) 2011, 25:930-937.
27. Rice O.V., Gatley S.J., Shen J., Huemmer C.L., Rogoz R., DeJesus O.T., et al. Effects of endogenous neurotransmitters on the in vivo binding of dopamine and 5-HT radiotracers in mice. Neuropsychopharmacology 2001, 25:679-689.
28. Barrett R.J., White D.K., Caul W.F. Tolerance, withdrawal, and supersensitivity to dopamine mediated cues in a drug-drug discrimination. Psychopharmacology (Berlin) 1992, 109:63-67.
29. Hillegaart V., Ahlenius S., Magnusson O., Fowler C.J. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response. Pharmacology, Biochemistry, and Behavior 1987, 27:159-164.